ClinicalTrials.Veeva

Menu

Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients

O

Olive View-UCLA Education & Research Institute

Status

Completed

Conditions

Septic Arthritis
Joint Infection

Study type

Observational

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT05341908
1577712

Details and patient eligibility

About

This is a prospective, observational study of patients presenting to the emergency departments at 9 EMERGEncy ID NET sites. The objectives of the proposed study are to:

  1. Describe the range and proportion of infectious agents in synovial fluid as detected by standard C&S and investigational PCR testing, i.e., Biofire® Film Array® Bone and Joint Infection (BJI) Panel,
  2. Describe the epidemiology of patients receiving diagnostic arthrocentesis and those diagnosed with septic arthritis in the emergency department (ED),
  3. Determine the prevalence of septic arthritis in US ED patients presenting with an atraumatic painful swollen joint, and
  4. Determine the clinical (history and physical examination) and laboratory characteristics of septic arthritis.

Study coordinators screen the ED log for adult patients presenting with joint pain and whose treating physician ordered an arthrocentesis. After confirming eligibility, study coordinators approach the patient to explain the study, and present the written consent form. If the patient agrees to participate and consent, the study coordinator completes an enrollment data collection using patient and treating physician interview to gather responses. After enrollment, the study coordinator will ensure that approximately 0.3-1.0 mL of leftover synovial fluid is saved and stored in a freezer for shipment to a central laboratory (Truman Medical Center hospital laboratory, Kansas City, MO) for testing. Approximately 30 days after enrollment, study coordinators complete an electronic medical record (EMR) review.

Enrollment

750 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 years and older;
  2. diagnostic arthrocentesis in the emergency department (ED) or during hospitalization if admitted from the ED;
  3. arthrocentesis and joint culture ordered; and
  4. provide written consent in English or Spanish

Exclusion criteria

  1. Unable to consent or no legal authorized representative is available; or
  2. prisoner or parolee

Trial contacts and locations

1

Loading...

Central trial contact

Greg Moran, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems